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On the Origin of Leprosy
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Leprosy, a chronic human disease with potentially debilitating neurological
consequences, results from infection with Mycobacterium leprae. This un-
culturable pathogen has undergone extensive reductive evolution, with half of
its genome now occupied by pseudogenes. Using comparative genomics, we
demonstrated that all extant cases of leprosy are attributable to a single
clone whose dissemination worldwide can be retraced from analysis of very
rare single-nucleotide polymorphisms. The disease seems to have originated
in Eastern Africa or the Near East and spread with successive human migra-
tions. Europeans or North Africans introduced leprosy into West Africa and
the Americas within the past 500 years.
Comparative genomics enables us to estab-
lish solid genealogical relationships with great-
er precision than ever before. Leprosy (1) has
plagued human populations for thousands of
years and puzzled scientists since the identifi-
cation of its etiological agent, Mycobacterium
leprae, by Hansen in 1873 (2). The main dif-
ficulties of working with M. leprae are that
it cannot be grown in axenic culture and
that its doubling time in tissue is slow, nearly
13 days (3). It was only when it was dis-
covered that the nine-banded armadillo, Das-
ypus novemcinctus, could be infected (4) that
sufficient quantities of M. leprae were obtain-
ed for biological and immunological anal-
ysis. Comparison of the genome sequence of
the armadillo-passaged strain of M. leprae
from Tamil Nadu, India (TN strain) with that
of the close relative Mycobacterium tubercu-
losis (5), led to a major breakthrough (6). M.
leprae was shown to have embarked upon a
path of reductive evolution in which the ge-
nome underwent downsizing and accumulated
more than 1130 pseudogenes. The concomi-
tant loss of catabolic and respiratory functions
appears to have resulted in severe metabolic
constraints (6, 7).
To establish whether all strains of M. leprae
had undergone similar events and to determine
their level of relatedness, we used technolog-
ical approaches that have successfully detect-
ed polymorphic regions in the M. tuberculosis
complex (8–10). First, genomic DNA, pre-
pared from seven different strains of leprosy
bacilli (Table 1), was hybridized to microar-
rays corresponding to the complete genome
of the TN strain, but no evidence for further
gene loss was uncovered in these isolates
(fig. S1). Second, to establish whether differ-
ences existed in the copy number of insertion-
sequence-like, dispersed repetitive sequences,
quantitative polymerase chain reaction was
performed to target the repetitive sequences
RLEP, REPLEP, LEPREP, and LEPRPT (11).
Again, within the limits of sensitivity of this ap-
proach, no differences were detected between
the TN strain and the other isolates (fig. S2).
A major source of variability in tubercle
bacilli is the mycobacterial interspersed repet-
itive unit (MIRU), which serves as the basis of
a robust typing system that exploits differences
in the variable number of the tandem repeats
Table 1. Strains of armadillo-derived M. leprae and VNTR profile.
Strain Patient’s country of origin Source 3-Hexa 21-TTC 9-GTA 14-AT 15-AT 17-AT 18-AT
Tamil Nadu* India IP 3 21 9 14 15 17 18
Africa Ethiopia IP 3 29 8 14 19 13 13
India 2 India IP 3 15 11 18 14 13 9
Br4923 Brazil NHDP 3 12 12 20 20 15 18
NHDP98 Mexico CSU/NHDP 3 10 9 22 14 11 12
Thai-53 Thailand CSU/NHDP 3 15 9 16 17 10 13
NHDP63 USA CSU/NHDP 3 10 10 18 18 13 16
*Numbers refer to the repeat copy number for the Tamil Nadu strain (11), whereas numbers in the rest of the table are the copy numbers found in the respective isolates. IP, Institut
Pasteur; NHDP, National Hansen’s Disease Program; CSU, Colorado State University.
1Unite´ de Ge´ne´tique Mole´culaire Bacte´rienne, Institut
Pasteur, Paris, France. 2PF2, Ge´nopole, Institut Pas-
teur, Paris, France. 3Centre National d’Appui a` la lutte
Contre la Maladie, Bamako, Mali. 4Department of Micro-
biology, Immunology, and Pathology, Colorado State
University, Fort Collins, Colorado 80523–1682, USA.
5National Hansen’s Disease Program, DHHS/HRSA/
BPHC, Lousiana State University, Baton Rouge, Lousiana
70894, USA. 6Leonard Wood Memorial Center for Lep-
rosy Research, Cebu, Philippines. 7Instituto Lauro de
Souza Lima, Bauru, Sa˜o Paulo, Brazil. 8Hoˆpital Saint-
Louis, Paris, France. 9Yonsei University College of Medi-
cine, Seoul, Republic of Korea. 10Bacte´riologie-Hygie`ne,
Faculte´ de Me´decine Pitie´-Salpeˆtrie`re, Paris, France.
11Instituto de Biomedicina, Caracas, Venezuela. 12Lon-
don School of Hygiene and Tropical Medicine, London,
UK. 13Institut Pasteur de Madagascar, Antananarivo,
Madagascar.
*These authors contributed equally to this work.
.To whom correspondence should be addressed:
E-mail: stcole@pasteur.fr
R E P O R T S
13 MAY 2005 VOL 308 SCIENCE www.sciencemag.org1040
(VNTR) that make up this repetitive element
(12). Unlike M. tuberculosis, none of the 20
MIRU loci in the TN strain contains tandem
repeats of the element (11) and, on examina-
tion of the additional strains, no copy number
differences were detected. Furthermore, the
20 MIRUs were of identical sequence in all
seven strains studied (Table 1). Seven other
VNTR, with two to six base-pair (bp) repeats,
were also targeted, because some of them
have proved useful for tracking strains over
short epidemiological distances (13–16). No
variation was seen in a hexanucleotide re-
peat situated within the coding sequence of
the sigA (rpoT) gene (17), whereas on exam-
ination of two trinucleotide repeats and four
dinucleotide repeats, located in pseudogenes
or noncoding regions of the genome, exten-
sive differences were seen in copy number
(Table 1). However, as expected for such se-
quences, which are highly prone to slipped-
strand mispairing during replication (18), the
level of variability was too great to allow pat-
terns to be detected.
Although these results rule out the exis-
tence of the most likely insertion and deletion
events, they are less informative about genome
topology and global organization. These fea-
tures were surveyed by fingerprinting and end-
sequencing 1466 cosmids from a library of a
second Indian strain of M. leprae, leading to
an integrated genome map that showed per-
fect cocircularity with that of the TN strain
(19, 20). To increase the likelihood of detect-
ing single-nucleotide polymorphisms (SNPs),
selected genes, noncoding regions, and pseudo-
genes were sequenced from a Brazilian strain,
Br4923 (table S1). This strain was chosen for
two reasons: the relative geographic remote-
ness of the country and the severity of the
disease burden in Brazil, which is second
highest worldwide after India (1). By this
means, five SNPs were revealed in 142 kb of
sequenced DNA, one in an apparently non-
coding region and four in pseudogenes. When
all seven strains were analyzed, only three of
the SNPs were found in two or more of the
strains tested (Fig. 1A), whereas the remain-
ing two were restricted to the TN strain of M.
leprae. Overall, the SNP frequency observed
in M. leprae of È1 per 28 kb was significantly
less than that seen in other human pathogens,
such as the tubercle bacilli (8, 9, 21, 22),
Salmonella typhi (23), and Helicobacter pylori
(24) (Table 2). Taken together, these findings
indicate that the M. leprae genome is excep-
tionally well conserved and that the leprosy
bacillus is highly clonal (25).
To gain insight into the worldwide distri-
bution of the M. leprae SNPs, we sought the
three informative SNPs in a total of 175 clini-
cal and laboratory specimens from 21 coun-
tries and all five continents. We discovered
that of a possible 64 permutations only 4 oc-
curred (Table 3 and table S2), referred to as
SNP types 1 to 4. When the VNTR panel was
probed, extensive variability was found for six
VNTRs (table S2), but no particular VNTR
pattern was associated with a given SNP type.
In contrast, a correlation exists between the
geographical origin of the leprosy patient and
the SNP profile, because type 1 occurs predom-
inantly in Asia, the Pacific region, and East
Africa, type 4 in West Africa and the Caribbe-
an region, and type 3 in Europe, North Africa,
and the Americas. SNP type 2 is the rarest and
has only been detected in Ethiopia, Malawi,
Nepal/North India, and New Caledonia.
Ancient texts describe the existence of
leprosy in China, India, and Egypt in about
600 BC, and skeletal remains bearing hall-
marks of the disease have been found in Egypt
(26). Leprosy is believed to have originated
in the Indian subcontinent and to have been
introduced into Europe by Greek soldiers re-
turning from the Indian campaign of Alexan-
Fig. 1. SNP analysis of isolates of different geographical origin and parsi-
mony. (A) Comparison of polymorphic sites in the genomes of the TN
and Br4923 strains by automated DNA sequencing. Coordinates are the
position in the genome of the TN strain, and the vertical bar indicates
the polymorphic base. (B) The most parsimonious route to account for
the four SNP types. Bold arrows indicate the most likely direction, based
on historical and geographic considerations; the faint arrow denotes an
alternative route.
Table 2. Comparison of SNP frequency in other
bacterial pathogens.
Pathogen SNP frequency/bp Reference
M. leprae 1 in 28,400 This work
M. tuberculosis
complex
1 in È3,000 (21, 22)
S. typhi 1 in 1,112 (23)
H. pylori 1 in 3.2 (24)
Table 3. SNP analysis of M. leprae from different
countries.
Country
SNP
type 1
SNP
type 2
SNP
type 3
SNP
type 4
New Caledonia 3 1 3
Philippines 19 2
Korea 3 2
Thailand 1
Nepal/North
India
23 5
South India 4
Madagascar 6
Ethiopia 2
Malawi 4 6
Mali 31
Ivory Coast 6
Guinea 1
Senegal 2
Morocco 2
France 2
Brazil 12 2
French West
Indies
4 2
Venezuela 5
Mexico 1
United States 3
WARM* 4
Total 67 14 38 56
*Wild armadillos from Louisiana, USA.
14
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der the Great (26). From Greece, the disease
is thought to have spread around the Mediter-
ranean basin, with the Romans introducing
leprosy into the Western part of Europe. Lit-
tle is known about its presence in sub-Saharan
Africa except that the disease was present
prior to the colonial era. From India, leprosy is
thought to have spread to China and then to
Japan, reaching Pacific Islands like New
Caledonia as recently as the 19th century.
Our results provide evidence for a general
evolutionary scheme for M. leprae and, on
the basis of our interpretation of the SNP data,
offer two alternative conclusions for the global
spread of leprosy that differ from classic ex-
planations. Two equally plausible evolution-
ary scenarios are possible (Figs. 1B and 2). In
the first, SNP type 2, from East Africa/Central
Asia, preceded type 1, which migrated east-
ward, and type 3, which disseminated west-
ward in human populations, before giving rise
to type 4. In the second scenario, type 1 was
the progenitor of type 2, with SNP types 3 and
4 following in that order.
Leprosy was most likely introduced into
West Africa by infected explorers, traders, or
colonialists of European or North African de-
scent, rather than by migrants from East Af-
rica, because SNP type 4 is much closer to
type 3 than to type 1 (Fig. 1B). West and south-
ern Africa are thought to have been settled
950,000 years ago by migrants from East Af-
rica before the arrival of humans in Eurasia
(27, 28). It seems unlikely that early humans
brought leprosy into West Africa with them
unless that particular bacterial clone has since
been replaced. From West Africa, leprosy was
then introduced by the slave trade in the 18th
century to the Caribbean islands, Brazil, and
probably other parts of South America, be-
cause isolates of M. leprae with the same SNP
type, 4, are found there as in West Africa.
The strain of M. leprae responsible for
disease in most of the Americas is closest to
the European/North African variety (Fig. 1B),
which indicates that colonialism and emigra-
tion from the old world most probably con-
tributed to the introduction of leprosy into the
new world. For instance, in the 18th and 19th
centuries, when the midwestern states of the
United States were settled by Scandinavian
immigrants, many cases of leprosy were re-
ported and, at that time, a major epidemic
was under way in Norway (26). Further sup-
port for this hypothesis is provided by the
finding that wild armadillos from Louisiana,
which are naturally infected with M. leprae,
harbor the European/North African SNP type 3
strain, indicating that they were contaminated
by human sources. Although most mycobac-
teria occur in the soil, there is no convincing
evidence for an environmental reservoir of M.
leprae and, apart from armadillos, which have
limited geographical distribution and only very
recently became infected, there is no known
animal source of the pathogen. Although an
ancient zoonotic origin cannot be excluded,
insect bites may also have been a possible
route of early human infection, particularly as
recent studies show that M. ulcerans, a related
pathogen with many pseudogenes, appears to
be transmitted by aquatic insects (29).
In conclusion, M. leprae, with its excep-
tionally stable genome, is a helpful marker
for tracking the migration of peoples and
retracing the steps that led to modern human
populations. In this respect, it complements
H. pylori, which is considerably more di-
verse and thus allows finer understanding of
the ethnic origin of humans (30). It is note-
worthy that the greatest variety of SNP types
in the leprosy bacillus is found in islands such
as the French West Indies and New Caledonia
(Fig. 2), reflecting the passage of, and set-
tlement by, different human populations. Fi-
nally, the remarkable clonality seen in isolates
of M. leprae indicates that genome decay oc-
curred prior to the global spread of leprosy and
that it has not accelerated substantially since.
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Fig. 2. Dissemination of leprosy in the world. The circles indicate the country of origin of the
samples examined and their distribution into the four SNP types, which are color coded as in Fig. 1B.
The colored arrows indicate the direction of human migrations predicted by, or inferred from, our
SNP analysis; gray arrows correspond to the migration routes of humans derived from genetic,
archaeological, and anthropological studies, with the estimated time of migration in years (27, 28).
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